Sterling, McCafferty, And BOE Policy
Sterling’s advance today is being attributed to comments by a member of the Bank of England’s Monetary Policy Committee McCafferty. However, we suspect it was a news item that was used to justify the price gains that was already underway. Sterling had been sold to a two-week low early yesterday as BOE Deputy Governor Broadbent confirmed our suspicions that he would side more with […]
Cenovus Energy: A Cheap Stock Worth Taking A Chance On
The big money when investing is when you can pick the beaten down stocks that will come back in a few years and net you a hefty profit. The great Peter Lynch called these “triplebaggers” as you triple your initial investment. One beaten down stock to look into is Cenovus Energy (NYSE: CVE). There are many factors […]
Better Dividend Aristocrat: Kimberly-Clark Or Colgate-Palmolive?
Kimberly-Clark (KMB) and Colgate-Palmolive (CL) have a lot in common. They are both giants in the consumer staples sector, and both have raised their dividends for several decades. Both stocks are Dividend Aristocrats. The Dividend Aristocrats Excel spreadsheet has 51 stocks with 25+ consecutive years of dividend increases. Kimberly-Clark has paid dividends for more than 80 years, […]
The Ingredients For A US Productivity Revival
It’s easy to find gloomy predictions for continued slow growth of the US economy. Thus, Lee Branstetter and Daniel Sichel caught my eye with their essay, “The Lee Branstetter and Daniel Sichel caught my eye with their essay, “The written as a “Policy Brief” for the Peterson Institute of International Economics (June 2017, PB17-26). Here how they start: […]
Billion Dollar Unicorns: Yello Mobile Delays IPO
South Korean Billion Dollar Unicorn club member Yello Mobile had been planning to go public this year. But recent financial results suggest that those plans may have been delayed by a year. Yello Mobile’s Offerings Sanghyuk Lee, a former executive at South Korean Internet company Daum Communications Corp founded Yello Mobile in 2013 to set up a company […]
USD/CAD Bearish Behavior To Persist As BoC Alters Policy Outlook
Ticker Last High Low Daily Change (pip) Daily Range (pip) NZD/USD 0.7319 0.7369 0.7247 55 122 NZD/USD breaks the monthly opening range following the semi-annual Humphrey-Hawkins testimony, but the near-term outlook remains riddled with mixed signs as the pair fails to test the 2017-high (0.7376). The price action from February may serve as a blueprint as […]
Another AMD Comeback: Stock Says Most Certainly Yes, But I’m Skeptical
At first glance you might very well think Advanced Micro Devices (AMD) is having a hugely successful rebirth. Here is two-year chart of the semiconductor company’s stock price: After so many fits and starts and promises over the last few decades, with little to show for it in the way of sustainable profitability, I had not really looked […]
4 Top-Ranked Non-US Mutual Funds For Steady Returns
Investors may find non-U.S. mutual funds more attractive than those with significant domestic exposure. Moreover, non-U.S. mutual funds are excellent choices for those looking to diversify their investments across a wide range of foreign countries including both emerging and developed nations. Thus, investing in non-U.S. mutual funds may prove profitable. Below we share with you […]
The Philly Fed ADS Business Conditions Index Update
Note: We’ve updated our periodic look at the Philly Fed ADS Index today’s release, which includes jobless claims through July 8. The Philly Fed’s Aruoba-Diebold-Scotti Business Conditions Index (hereafter the ADS index) is a fascinating but relatively little known real-time indicator of business conditions for the U.S. economy, not just the Third Federal Reserve District, […]
5 Pharma & Biotech Stocks That Could Be Big Winners In Q2 Earnings
Drug stocks have bounced back this year with the Nasdaq Biotechnology Index and the NYSE ARCA Pharmaceutical Index gaining 18.6% and 10.8%, respectively, year-to-date (YTD). There are several reasons for this improved performance. Investors are now more comfortable with the drug pricing scenario and are willing to look at the fundamentals of the sector. […]
